Megan Linders, DO
Family Medicine · Post Falls, IDNPI 1336704253
Payments from drug & device makers
Across 34 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$189
- Novo Nordisk$72
- GSK$68
- Amgen$41
- AstraZeneca$38
- Philips North America LLC$37
- plus $304 from 12 others
What the payments were for
- Food & beverage$750100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 9 | $189 |
| Novo Nordisk | 4 | $72 |
| GSK | 3 | $68 |
| Amgen | 2 | $41 |
| AstraZeneca | 2 | $38 |
| Philips North America LLC | 1 | $37 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $35 |
| Lilly USA, LLC | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $32 |
| Exact Sciences | 1 | $32 |
| Sanofi | 1 | $30 |
| Edwards Lifesciences | 1 | $27 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Boston Scientific | 1 | $21 |
| Merck | 1 | $19 |
| Dexcom, Inc. | 1 | $18 |
| Verona Pharma, Inc. | 1 | $14 |
How this compares
$750 in reported general payments places this provider in the 70th percentile of 803 family medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $592 |
| Gabapentin | 17 | $582 |
| Omeprazole | 21 | $530 |
| Atorvastatin Calcium | 35 | $430 |
| Losartan Potassium | 38 | $430 |
| Topiramate | 11 | $416 |
| Levothyroxine Sodium | 19 | $277 |
| Pantoprazole Sodium | 11 | $251 |
| Metoprolol Succinate | 14 | $167 |
| Lisinopril | 24 | $148 |
| Mirtazapine | 11 | $99 |
| Metformin Hcl | 12 | $92 |
| Amlodipine Besylate | 18 | $84 |
| Fluticasone Propionate | 11 | $55 |
| Metformin Hcl ErMetformin Hcl | 15 | $51 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Post Falls
- Michael MonohanPost Falls$8K
- Morgan FordPost Falls$8K
- Anthony PetersPost Falls$6K
- Chad ScarolaPost Falls$6K
- Mark TurnerMeridian$40.5M
- David ButukMeridian$15.2M
- Gary SoucieBlackfoot$5.8M
- Brock McConneheyBoise$4.5M
- William LaitinenMiddleton$1.1M
- Diane McConneheyBoise$681K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.